Abstract
Recent progress in molecular medicine has provided important tools to identify antigen-specific T cells. In most cases, the approach is based on oligomeric combinations of recombinant major histocompatibility complex–peptide complexes fixed to various rigid supports available for binding by the T-cell receptor1,2,3,4,5,6,7,8. These tools have greatly increased our insight into mechanisms of immune responses mediated by CD8+ T cells1,2. Examples of the diverse fields of application for this technology include immunization, viral infections and oral tolerance induction1,2,3,4,5,6.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96 (1996).
Davis, M.M. et al. Ligand recognition by alpha beta T-cell receptors. Annu. Rev. Immunol. 16, 523–544 (1998).
Lee, P.P. et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature Med. 5, 677–854 (1999).
Kirsten, J. et al. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8, 683–691 (1998).
Mutis, T. et al. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nature Med. 5, 839–842 (1999).
Greten, T. et al. Direct visualization of antigen-specific T cells: HTLV-1-specific CD8+ T cells are activated in peripheral blood and accumulate in CSF from HAM/TSP patients. Proc. Natl. Acad. Sci. USA 95, 7568–7573 (1998).
Lusembourg, A.T. et al. Biomagnetic isolation of antigen-specific CD8+ T cells usable in immunotherapy. Nature Biotechnol. 16, 281–285 (1998).
Crawford, F., Kozono, H., White, J., Marrack, P. & Kappler, J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8, 675–682 (1998).
Grakoui, A. et al. The immunological synapse: A molecular machine controlling T-cell activation. Science 285, 221–227 (1999).
Albani, S. et al. Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nature Med. 1, 448–452 (1995).
La Cava, A. et al. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J. Clin. Invest. 100, 658–663 (1997).
Anderson, D.E. et al. Weak peptide agonists reveal functional differences in B7–1 and B7-2 costimulation of human T-cell clones. J. Immunol. 159, 1669–1675 (1997).
Nanda, N.K. & Sercarz, E.E. Induction of anti-self-immunity to cure cancer. Immunol. Today 19, 495–498 (1998).
Moalem, G. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Med. 5, 49–55 (1999).
Brian, L. et al. Use of soluble peptide–DR4 tetramers to detect synovial T cells specific for cartilage antigen in patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 97, 291–296 (2000).
Rees, W. et al. An inverse relationship between T-cell receptor affinity and antigen dose during CD4(+) T-cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96, 9781–9786 (1999).
Janssen, E.M. et al. Modulation of Th2 responses by peptide analogues in a murine model of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J. Immunol. 164, 580–588 (2000).
Bonnin, D. et al. Ontogeny of synonymous T cell populations with specificity for a self MHC epitope mimicked by a bacterial homologue: an antigen-specific T cell analysis in a non-transgenic system. Eur. J. Immunol. 29, 3826–3836 (1999).
Barton, G.M. & Rudensky, A.Y. Requirement for diverse, low-abundance peptides in positive selection of T cells. Science 283, 67–70 (1999).
Viola, A., Schroeder, S., Sakakibara, Y. & Lanzavecchia, A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283, 680–682 (1999).
Sette, A. et al. Effect of pH on MHC class II-peptide interactions. J. Immunol. 148, 844–851 (1992).
Van Rensen, A.J.M.L., Wauben, M.H.M., Grosfeld-Stulemeyer, M.C., Van Eden, W. & Crommelin, D.J.A. Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T-cell activation. Pharm. Res. 16, 198–204 (1999).
Acknowledgements
We thank D. Bonnin, D. Schuijffel, S. Nijenhuis and E. Quintela for technical support and assistance. We also thank Nicole Lewon for assistance in editing the manuscript. This study was supported in part by grants NO1-AR40770, NO1-AR44850, NO1-AR72232, NO1-AR41897 and NO1-AR92241. B.P. is supported by the `Ter Meulenfonds' of the Royal Netherlands Academy of Arts and Sciences and by the Dutch Rheumatoid Arthritis Foundation. M.W. is supported by a fellowship from the Royal Netherlands Academy of Arts and Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prakken, B., Wauben, M., Genini, D. et al. Artificial antigen-presenting cells as a tool to exploit the immune `synapse'. Nat Med 6, 1406–1410 (2000). https://doi.org/10.1038/82231
Issue Date:
DOI: https://doi.org/10.1038/82231